entertainment -WSS

entertainment

author：knowledge 2025-09-27 23:01:05 - browse：89

Bristol Myers Squibb sign — Courtesy Bristol Myers Squibb

Bristol Myers Squibb will pay $4.1 billion for RayzeBio, the companies said Tuesday, buying into the fast-growing field of using targeted doses of radiation to treat cancer.

RayzeBio, which raised about $350 million in a September initial public offering, is working in radiopharmaceuticals, which pair the tumor-killing power of radiation with the precision of targeted cancer therapies. The company is currently running a pivotal trial of its most advanced drug, RYZ101, in neuroendocrine cancer and has a pipeline of treatments for kidney, liver, and other cancers.

Bristol Myers will pay $62.50 in cash per share of RayzeBio, a roughly 115% premium to the company’s recent trading and more than triple the company’s IPO price.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： What we know about the American soldier detained in North Korea

WSS

Will an HIV vaccine ever be a reality?

Biden administration sends mixed signals on US soldier who crossed into North Korea

Will an HIV vaccine ever be a reality?

Experts study whether long Covid risk adds up with each reinfection

RSV injection headlines need to be accurate for good uptake

15 die by electrocution after transformer explodes in northern India

explore

entertainment

hotspot

Cancer drug shortages should be causing more outrage

Johnson & Johnson sues to stop Medicare negotiation

At least 13 dead in Texas as scorching temps continue

Robert Kennedy Jr.'s presidential campaign attracts GOP

Malaria cases in Florida and Texas: Here’s what you need to know

US soldier in North Korean custody after crossing DMZ line

As demand for Covid shots wanes, Moderna seeks its next success

What we owe ALS patients — and why one company fell short

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Israeli protesters block highways, train stations as Netanyahu moves ahead with judicial overhaul

explore

More hospitals are billing patients as online messages surge

CRISPR base editing slashes cholesterol levels in monkeys

The United States is paying nearly triple for new Covid vaccines

Lack of darker skin in textbooks, journals harms patients of color

With Roe v Wade overturned, abortion providers work to adapt

Readout Newsletter: Biotech news, Wall Street disappointment, Lilly's drug delays

hotspot

leisure time

hotspot

focus